drugset / Trial / NCT00498004

Quality of Life (QOL) in Female Patient With Schizophrenia

NCT00498004

Phase 4 Terminated 100 enrolled Inje University
RandomizedParallel-groupOpen-labelTreatment

Summary

The primary objective of this study is to demonstrate clinical and statistical superiority of quetiapine compared to risperidone in Korean version of Heinrich's Quality of Life Scale after 8 weeks trial of drugs.

Timeline

Start
2007-08
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule 400 mg
Subject Quetiapine Small molecule 800 mg
Subject Risperidone Other / unclassified 4 mg
Subject Risperidone Other / unclassified 6 mg

Indications